Do I need to adjust the renal dose of amoxicillin‑clavulanate (Augmentin) for acute bacterial sinusitis in an adult with an estimated glomerular filtration rate of 44 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Renal Dose Adjustment for Augmentin in Sinusitis with GFR 44

Yes, you need to adjust the dose of amoxicillin-clavulanate (Augmentin) for acute bacterial sinusitis when the GFR is 44 mL/min, but the standard 875/125 mg formulation can still be used with modified frequency.

Renal Dosing Recommendations

For GFR 30–50 mL/min (which includes your patient with GFR 44):

  • No dose adjustment is required for the standard 875 mg/125 mg formulation—continue twice daily dosing as normal. 1
  • The FDA label explicitly states that "patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe" (defined as GFR <30 mL/min). 1

For GFR 10–30 mL/min:

  • Reduce frequency to 500 mg/125 mg or 250 mg/125 mg every 12 hours (depending on infection severity). 1

For GFR <10 mL/min:

  • Further reduce to 500 mg/125 mg or 250 mg/125 mg every 24 hours. 1
  • Hemodialysis patients require an additional dose both during and at the end of dialysis. 1

Standard Sinusitis Dosing at GFR 44

Your patient can receive the full standard regimen:

  • Amoxicillin-clavulanate 875 mg/125 mg orally twice daily for 5–10 days (or until symptom-free for 7 consecutive days, typically 10–14 days total). 2, 3, 4
  • This provides 90–92% predicted clinical efficacy against the three major sinusitis pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis). 2, 3

High-Dose Regimen Considerations

If high-dose therapy is indicated (recent antibiotic use, age >65, daycare exposure, moderate-to-severe symptoms, comorbidities, immunocompromised state):

  • The 2 g/125 mg twice daily regimen is also safe at GFR 44 mL/min, as the FDA cutoff for dose reduction is GFR <30 mL/min. 1
  • However, avoid the 875 mg/125 mg dose in patients with GFR <30 mL/min per FDA labeling. 1

Monitoring and Reassessment

  • Reassess at 3–5 days: If no improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch to a respiratory fluoroquinolone (levofloxacin 500 mg daily or moxifloxacin 400 mg daily). 2, 3, 4
  • Reassess at 7 days: Persistent or worsening symptoms warrant diagnostic reconsideration, exclusion of complications, and possible ENT referral. 2, 3

Essential Adjunctive Therapies

  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and accelerate symptom resolution—supported by strong evidence from multiple RCTs. 2, 3, 4
  • Saline nasal irrigation 2–3 times daily provides symptomatic relief and aids mucus clearance. 2, 3
  • Analgesics (acetaminophen or ibuprofen) for pain and fever control. 2, 3

Common Pitfall to Avoid

  • Do not unnecessarily reduce the dose when GFR is 30–50 mL/min; the FDA explicitly permits standard dosing in this range, and underdosing may lead to treatment failure. 1
  • Gastrointestinal adverse effects (diarrhea in 40–43% of patients; severe diarrhea in 7–8%) are common with amoxicillin-clavulanate but are not increased by renal impairment at this GFR level. 2, 4

References

Guideline

Amoxicilina-Ácido Clavulánico Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Optimized Augmentin Therapy for Acute Bacterial Sinusitis in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.